Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 17, 2026 16:05 ET | Source: Theriva Biologics, Inc.

Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting

- Tumor reponse, biomarker, and subgroup analyses from the VIRAGE Phase 2b clinical trial support a VCN-01 immune-mediated mode of action and demonstrate improved outcomes in VCN-01 treated patients...
April 17, 2026 16:05 ET | Source: ORIC Pharmaceuticals

ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Research (AACR) Annual Meeting

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 17, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that...
April 17, 2026 16:01 ET | Source: Adagene Inc.

Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types

Triple combination of muzastotug + atezolizumab + bevacizumab resulted in much higher overall response rates (ORR) compared to the atezolizumab + bevacizumab control arm (66.7% vs. 32.5%, respectively...
April 17, 2026 15:00 ET | Source: Zymeworks Inc.

Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform

Six poster presentations showcase Zymeworks’ next-generation ADC programs, including multiple first-in-class pan-RAS inhibitor ADCs Data highlight efficacy, tumor-selective delivery, and favorable...
April 17, 2026 15:00 ET | Source: Asgard Therapeutics

Asgard Therapeutics to present preclinical data on lead asset AT-108, a personalized, off-the-shelf gene therapy, at AACR Annual Meeting 2026

Asgard Therapeutics to present a poster on its lead asset AT-108, a personalized, off-the-shelf gene therapy, at AACR Annual Meeting 2026.
April 17, 2026 13:12 ET | Source: Jelly Lean

JellyLean Claims Evaluated: Discover the Untold Truth About Jelly Lean Gelatin Trick Gummies Recipe for Weight Loss

JellyLean Claims Evaluated: gelatin trick gummies recipe for weight loss reviews for ingredients, pricing, and 60-day refund policy reviewed for 2026.
April 17, 2026 13:07 ET | Source: Beond, Inc.

Beond Establishes U.S. Headquarters in Austin as Texas Leads the Nation Into a New Era of Brain Health

AUSTIN, Texas, April 17, 2026 (GLOBE NEWSWIRE) -- Texas is rewriting the future of mental health. With a $100 million commitment to ibogaine research, a growing coalition of clinicians, policymakers,...
April 17, 2026 12:20 ET | Source: Research and Markets

Radiology AI Global Market Research and Forecast Report 2026-2030: Opportunities in Growing Demand for Platform, Multi-Modal Data, and OEM Integration (Pacs/Ehr/Marketplaces)

Dublin, April 17, 2026 (GLOBE NEWSWIRE) -- The "Radiology AI Market by Offering, Function, Modality, Indication, End User, Region - Global Forecast to 2030" has been added to ...
April 17, 2026 10:27 ET | Source: Research and Markets

$5.59 Bn Electric Trucks Global Market Forecasts to 2032 - Growing Collaborations Among Manufacturers, Battery Innovators, and Digital Platform Developers

Dublin, April 17, 2026 (GLOBE NEWSWIRE) -- The "Electric Trucks Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Electric Trucks Market was valued...
April 17, 2026 10:19 ET | Source: Mordor Intelligence

Sneakers Market Size to Reach $143.6 Billion by 2031 Growing at 7.41% CAGR, Driven by Athleisure Trends and E-Commerce Expansion, Says Mordor Intelligence

Hyderabad, April 17, 2026 (GLOBE NEWSWIRE) -- According to a research report by Mordor Intelligence, the sneaker market size was estimated at $94.61 billion in 2025, and is projected to expand...